President and CEO
Mr. Daniel serves as Chief Executive Officer and President of CCI, primarily responsible for business development, growth and fund-raising needs of CCI. His most recent and current business experience is Vice President of Sales and Marketing for Myelotec, Inc., a medical device manufacturing company. Prior to Myelotec, Mr. Daniel was the Vice President of Market Development for Spheringenics – a stem cell research company focused on cosmetic restoration utilizing a unique method of harvesting and delivering cells via microspheres. Mr. Daniel was previously president of Allograft Solutions, Inc., a tissue engineering company.
Tom Barrows, PhD
Executive Vice President and CSO
Dr. Barrows is responsible for operations and research and is the inventor of CCI’s biomaterials technology. His career in biomedical materials research began after obtaining a PhD in organic chemistry from the Pennsylvania State University and includes 22 years at 3M where he invented and developed bioabsorbable polymers and surgical devices including tissue sealants. He was recruited to join a start-up venture in the Boston area in 1996 to continue research on tissue sealants. From there he relocated to Atlanta, GA and co-founded BioAmide, Inc. and began applying tissue engineering principles to the development of solutions for hair restoration, which led to the acquisition of BioAmide in 2002 by Bosley/Aderans (Aderans, Ltd., Tokyo, Japan) and simultaneous formation of the Aderans Research Institute, Inc. (ARI). In 2008 he left ARI and co-founded CCI with the goal of utilizing stem cells to cure chronic wounds. Dr. Barrows is a member of the Society for Biomaterials and the American Chemical Society.